Diagnostic Medical SystemsFRA:DMS1 65 PB Ratio is 1.51 as of Jul. 04, 2026, which is 21% above its 10-year median of 1.25. GuruFocus rates FRA:DMS1 with a GF Score™ of 65/100 and a GF Value™ of €1.03 (Fairly Valued). The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Diagnostic Medical Systems ranks better than 61.63% on this metric.
Diagnostic Medical Systems stock PB Ratio (=1.68) is close to 1-year low of 1.65.
The historical rank and industry rank for Diagnostic Medical Systems's PB Ratio or its related term are showing as below:
FRA:DMS1'
s PB Ratio Range Over the Past 10 Years
Min: 0.48 Med: 1.25 Max: 2.22
Current: 1.68
During the past 13 years, Diagnostic Medical Systems's highest PB Ratio was 2.22. The lowest was 0.48. And the median was 1.25.
FRA:DMS1's PB Ratio is ranked better than 61.63% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs FRA:DMS1: 1.68
During the past 12 months, Diagnostic Medical Systems's average Book Value Per Share Growth Rate was 15.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -8.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -10.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -8.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Diagnostic Medical Systems was 2.20% per year. The lowest was -26.30% per year. And the median was -9.35% per year.
Back to Basics: PB Ratio
Diagnostic Medical Systems (FRA:DMS1) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Diagnostic Medical Systems PB Ratio Related Terms
Diagnostic Medical Systems PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Diagnostic Medical Systems's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's PB Ratio distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Diagnostic Medical Systems (FRA:DMS1) has a PB Ratio of 1.51 as of Jul. 04, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Diagnostic Medical Systems and its competitors. This is 21% above median its historical median of 1.25. Over the past decade, Diagnostic Medical Systems' PB Ratio has ranged from 0.48 to 2.22. According to the industry distribution chart, Diagnostic Medical Systems ranks #302 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 38.4%.
Is Diagnostic Medical Systems' PB Ratio too high?
Diagnostic Medical Systems' current PB Ratio of 1.51 is 21% above median its 10-year median of 1.25. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 2.22. The Medical Devices & Instruments industry median PB Ratio is 2.09. Diagnostic Medical Systems' value of 1.51 is 27.8% below this industry median. Based on the distribution chart, Diagnostic Medical Systems ranks #302 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Diagnostic Medical Systems has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #302 out of 787 companies for PB Ratio. This puts Diagnostic Medical Systems in the upper half of its industry. The industry median PB Ratio is 2.09. Diagnostic Medical Systems' value of 1.51 is 27.8% below this benchmark. Historically, Diagnostic Medical Systems' own PB Ratio has ranged from 0.48 to 2.22 over the past decade. While the company's 10-year median is 1.25 vs. the industry median of 2.09, Diagnostic Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.09, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostic Medical Systems's current PB Ratio of 1.51 is 27.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Diagnostic Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current PB Ratio is 1.51, which is 21% above median its own 10-year median of 1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (FRA:DMS1) is currently considered Fairly Valued. The stock's GF Value™ is €1.03, compared to a current price of €1.12 — trading 8.3% above its estimated fair value. The current PB Ratio is 1.51, which is 21% above median its 10-year median of 1.25 and 27.8% below the Medical Devices & Instruments industry median of 2.09. Diagnostic Medical Systems' overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Diagnostic Medical Systems (FRA:DMS1), the current PB Ratio is 1.51 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (FRA:DMS1) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued.
The current stock price of €1.12 is trading 8.3% above its estimated GF Value™ of €1.03.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for FRA:DMS1:
PB Ratio: 1.51 (21% above median its 10-year median of 1.25)
GF Value™: €1.03 vs. price of €1.12 (8.3% above fair value)
Industry Position: 27.8% below the Medical Devices & Instruments median (#302 of 787)
No single metric tells the full story. See the FRA:DMS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
65GF Score
Get the complete analysis for FRA:DMS1
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DMS1 has been successfully added to your 
